TEL AVIV, Israel--(BUSINESS WIRE)--Figures reported by the Chief Scientist office towards the "ILSI-Biomed Israel 2008" Week, which will be held in Tel Aviv from May 27-29, show that in the six months from November 2007 to April 2008, the Chief Scientist office earmarked 305.4 million NIS in budgets for the life science industry. When broken down into industry segments, bio-pharma received 77 million NIS, biotechnology 153.9 million NIS, and medical devices 74.5 NIS. In all, the Chief Scientist processed applications from 49 companies for support in 100 specific projects. Of the 305.4 million NIS given to the life science industry, research and development budgets accounted for 122.5 NIS.
